Gregor MacRae
Corporate Officer/Principal en Appledore Wealth Management LLP .
Cargos activos de Gregor MacRae
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Appledore Wealth Management LLP | Corporate Officer/Principal | - | - |
Historial de carrera de Gregor MacRae
Antiguos cargos conocidos de Gregor MacRae.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 21/01/2020 | 18/06/2020 |
| OKYO PHARMA LIMITED | Director/Miembro de la Junta | 19/12/2019 | 10/06/2020 |
Formación de Gregor MacRae.
| University of Birmingham | Graduate Degree |
Estadísticas
Internacional
| Reino Unido | 4 |
| Bermudas | 2 |
Operativa
| Director/Board Member | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| Empresas privadas | 2 |
|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
| Appledore Wealth Management LLP |
- Bolsa de valores
- Insiders
- Gregor MacRae
- Experiencia
